Patents by Inventor So Hyun HWANG

So Hyun HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NATURAL KILLER CELL HAVING CONTROLLED ONCOLOGY-RELEATED GENE EXPRESSION, AND USE THEREOF
    Publication number: 20230257710
    Abstract: A method of culturing high-purity, highly active natural killer cells of which expression of anti-cancer-related gene is regulated, and use thereof for anticancer immunotherapy are provided. In the natural killer cells, the expression of anticancer related genes is significantly increased or decreased before and after culture. The natural killer cells have the unique characteristics thereof, and remarkably high activity and proliferation fold. Therefore, the natural killer cells can be used for effective anticancer immunotherapy.
    Type: Application
    Filed: April 14, 2023
    Publication date: August 17, 2023
    Inventors: Young Seok BAEK, Hee Jung AN, Myung Seo KANG, Yong Wha MOON, Kyung Soon PARK, In Jee LEE, So Hyun HWANG
  • BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO IMMUNE THERAPEUTIC AGENT
    Publication number: 20230002833
    Abstract: The disclosure relates to biomarkers for predicting a therapeutic response of a patient to an immune therapy. Since gene signatures and markers according to an aspect have an excellent predictive capacity for predicting a patient's therapeutic response to an immune therapy, a patient group predicted to exhibit therapeutic effects may be selected to perform an appropriate treatment, and a patient's suffering and costs may be reduced.
    Type: Application
    Filed: November 10, 2020
    Publication date: January 5, 2023
    Applicant: SUNGKWANG MEDICAL FOUNDATION
    Inventors: So Hyun HWANG, Jae Joon LIM, Kwang Yul CHA, Hee Jung AN, Hae Youn KANG, Kyung Gi CHO, Jin Hyung HEO, Je-Gun JOUNG, Se Wha KIM, Ah Young KWON